Carisma Therapeutics Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
Carisma Therapeutics Inc. quarterly Lessee, Operating Lease, Liability, to be Paid history and growth rate from Q1 2019 to Q2 2024.
  • Carisma Therapeutics Inc. Lessee, Operating Lease, Liability, to be Paid for the quarter ending June 30, 2024 was $2.28M, a 40.8% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $2.28M -$1.57M -40.8% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $5.91M +$1.88M +46.7% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $2.61M Dec 31, 2023 10-K 2024-04-01
Q3 2023 $2.13M Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $3.85M Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $4.03M Mar 31, 2023 10-Q 2023-05-11
Q4 2021 $129K -$155K -54.6% Dec 31, 2021 10-K 2022-02-28
Q4 2020 $284K +$171K +151% Dec 31, 2020 10-K 2021-03-15
Q4 2019 $113K Dec 31, 2019 10-K 2020-03-16
Q3 2019 $151K Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $189K Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $232K Mar 31, 2019 10-Q 2019-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.